This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FRTX

Fresh Tracks Therapeutics (FRTX) Stock Price, News & Analysis

Fresh Tracks Therapeutics logo

About Fresh Tracks Therapeutics Stock (NASDAQ:FRTX)

Key Stats

Today's Range
$0.94
$0.94
50-Day Range
$0.94
$0.94
52-Week Range
$0.03
$1.03
Volume
N/A
Average Volume
2,709 shs
Market Capitalization
$5.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresh Tracks Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FRTX Stock News Headlines

Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
Fresh Tracks Therapeutics Inc (FRTX)
See More Headlines

FRTX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresh Tracks Therapeutics investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Today
6/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:FRTX
CIK
819050
Web
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$10.06 million
Price / Sales
0.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.66 per share
Price / Book
0.56

Miscellaneous

Outstanding Shares
5,973,000
Free Float
5,959,000
Market Cap
$5.58 million
Optionable
Not Optionable
Beta
0.54
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:FRTX) was last updated on 6/20/2026 by MarketBeat.com Staff.
From Our Partners